Clinical practices in neonatal oxygenation: Where have we failed? What can we do?

Journal of Perinatology

Volumn 28, Issue , 2008, Pages S28-S34

  Sola, A ^a   Saldeno Y P ^a,b   Favareto, V ^a,c  

^a Atlantic Health   (United States)

^b Servicio Gallego de Salud   (Spain)

^c Hospital Provincial de Rosario   (Argentina)

Author keywords

Neonatal clinical practices; Outcome improvement; Oxygen; Oxygen saturation; Oxygenation; Pulse oximetry

Indexed keywords

OXYGEN;

ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; CELL DAMAGE; CLINICAL EDUCATION; CLINICAL PRACTICE; CONFERENCE PAPER; HEALTH CARE PERSONNEL; HUMAN; NEWBORN CARE; NEWBORN MONITORING; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; OXYGEN TOXICITY; OXYGENATION; PRACTICE GUIDELINE; TISSUE INJURY;

ANOXIA; BRAIN DAMAGE, CHRONIC; BRONCHOPULMONARY DYSPLASIA; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; MONITORING, PHYSIOLOGIC; OXYGEN; OXYGEN INHALATION THERAPY; REFERENCE VALUES; RETINOPATHY OF PREMATURITY;

EID: 43049102750     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.47     Document Type: Article

References (66)

1. Comroe JH. How to delay progress without even trying. In: Retrospectroscope. Insights into Medical Discovery. Von Gehr Press: Mento Park, California, 1977, pp 114–119.
2. Sola A, Lee BH. Education in oxygenation has been insufficient: A need for darning. Presented at: the 2007 Society for Pediatric Research: Toronto, Canada.
3. Comroe JH, Bahnson ER, Coates EO. Mental changes occurring in chronically anoxemic patients during oxygen therapy. J Am Med Assoc 1950; 143: 1044–1048.
4. Aust AE, Eveleigh JF. Mechanisms of DNA oxidation. Exp Biol Med 1999; 222: 246– 252.
5. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. J Biol Chem 1991; 266: 2005–2008.
6. Sola A, Rogido M, Deulofeut R. Oxygen as a neonatal health hazard: call for detente in clinical practice. Acta Paediatr 2007; 96: 798–800.
7. Sola A, Chow L, Rogido M. Pulse oximetry in neonatal care in 2005. A comprehensive state of the art review. An Pediatr (Barc) 2005; 62: 266–281.
8. Bohnhorst B, Peter CS, Poets CF. Detection of hyperoxaemia in neonates: data from three new pulse oximeters. Arch Dis Child Fetal Neonatal Ed 2002; 87(3): F217–F219.
9. Workie FA, Rais-Bahrami K, Short BL. Clinical use of new-generation pulse oximeters in the neonatal intensive care unit. Am J Perinatol 2005; 22(7): 357–360.
10. Robertson FA, Hoffman GM. Clinical evaluation of the effects of signal integrity and saturation on data availability and accuracy of Masimo SE and Nellcor N-395 oximeters in Children. Anesth Analg 2004; 98(3): 617–622.
11. Hay WW, Rodden DJ, Collins SM, Melara DL, Hale KA, Fashaw LM. Reliability of conventional and new pulse oximetry in neonatal patients. J Perinatol 2002; 22(5): 360–366.
12. Fowler WS, Comroe JH. Lung function studies. I. The rate of increase of arterial oxygen saturation during the inhalation of 100% O2. J Clin Invest 1948; 27: 327–334.
13. Nicolini U, Nicolaidis P, Fisk N, Vaughan JI, Fusi L, Gleeson R et al. Limited role of fetal blood sampling in prediction of outcome in intrauterine growth retardation. Lancet 1990; 336: 768–772.
14. Kamlin CO, O’Donnell CP, Davis PG, Morley CJ. Oxygen saturation in healthy infants immediately after birth. J Pediatr 2006; 148(5): 585–589.
15. Mariani G, Dik PB, Ezquer A, Aguirre A, Esteban ML, Perez C et al. Pre-ductal and post-ductal O2 saturation in healthy term neonates after birth. J Pediatr 2007; 150(4): 418–421.
16. Vijayakumar E, Ward GJ, Bullock CE, Patterson ML. Pulse oximeter in infants <1500 gm birth weight on supplemental oxygen: a national survey. J Perinatol 1997; 17: 341–345.
17. Castillo A, Sola A, Baquero H et al. Pulse oximetry saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: Is 85% to 93% an acceptable range?. Pediatrics (in press).
18. Sola A, Chow L, Rogido M. Retinopathy of prematurity and oxygen therapy: a changing relationship. An Pediatr (Barc) 2005; 62: 48–63.
19. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 2005; 115: 997–1003.
20. Gressens P, Rogido M, Paindaveine B, Sola A. The impact of neonatal intensive care practices on the developing brain. J Pediatr 2002; 140(6): 646–653.
21. Peng J, Peng L, Stevenson FF, Doctrow SR, Andersen JK. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson’s disease accelerate age-related neurodegeneration. J Neurosci 2007; 27(26): 6914–6922.
22. Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging 2007; 28: 907–913.
23. Sola A, Rogido MR. Iron, oxidation and preterm infants. J Pediatr (in press).
24. Sola A. Turn off the lights and the oxygen, when not needed: phototherapy and oxidative stress in the neonate. J Pediatr (Rio J) 2007; 83(4): 293–296.
25. Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997; 350: 12–14.
26. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al., Early treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005; 116: 15–23.
27. Silverman WA. Retrolental Fibroplasia: A Modern Parable. Grune and Startton: New York, 1980. Available at: http://www. neonatology.org/classic/parable/default.html.
28. Cross KW. Cost of preventing retrolental fibroplasia? Lancet 1973; 2: 946–954.
29. Bolton DPG, Cross KW. Further observations on cost of preventing retrolental fibroplasia. Lancet 1974; 1: 445–448.
30. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB et al. Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology 1991; 98: 1628–1640.
31. Flynn JT, Bancalari E, Bachynski BN, Buckley EB, Bawol R, Goldberg R et al. Retinopathy of prematurity. Diagnosis, severity and natural history. Ophthalmology 1987; 94: 620–629.
32. Flynn JT. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 1983; 81: 549–591.
33. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B et al. Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematury cooperative group. Ophtalmology 1993; 100(2): 230–237.
34. Flynn JT, Bancalari E, Snyder E, Goldberg RN, Feuer W, Cassady J et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050–1054.
35. Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004; 14(suppl A): S140–S144.
36. Penn JS, Henry MM, Toldman BL. Exposure to alternating hypoxia and hyperoxia cause severe proliferative retinopathy in the newborn rat. Pediatr Res 1994; 36: 731–774.
37. York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very low birth weight infants. J Perinatol 2004; 24: 82–87.
38. Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fuyimura M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol 1993; 231: 151–156.
39. Chow LC, Wright WK, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339–345.
40. Deulofeut R, Critz A, Adams-Chapman I, Sola A. Avoiding hyperoxia in infants r1250 grams is associated with improved short- and long term outcomes. J Perinatol 2006; 26: 700–705.
41. Kim TI, Sohn J, PI SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004; 18: 130–134.
42. Tin W, Milligan WA, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84: F106–F110.
43. Gramlicht T. Oxygen therapy. In: Barnhart SL, Czervinske MP (eds). Perinatal and Pediatric Respiratory Care. WB Saunders: Philadelphia, PA, 1995, pp 156–179.
44. Wright KW, Sami D, Thompson L, Ramanathan R, Joseph R, Farzavandi S. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 2006; 104: 78–84.
45. Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS 2006; 10(5): 445–448.
46. Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol 2006; 26(suppl 1): S46–S50.
47. Wallace DK, Veness-Meehan KA, Miller WC. Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J AAPOS 2007; 11(2): 170–174.
48. Deulofeut R, Sola A. Risk for late bacterial sepsis in infants <1000 grs: another beneficial effect of avoiding hyperoxia? E-PAS 2006; 59: 2851.14830.
49. Deulofeut R, Dudell G, Sola A. Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Acta Paediatr 2007; 96: 990–994.
50. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 2001; 50: 712–719.
51. Klinger G, Beyene J, Shah P, Perlman M. Do hyperoxemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia? Arch Dis Child Fetal Neonatal Ed 2005; 90: F49–F52.
52. Macey PM, Woo MA, Harper RM. Hyperoxic brain effects are normalized by addition of CO2. PLoS Med 2007; 4(5): e173.
53. Saugstad OD, Ramji S, Vento M. Resuscitation of depressed newborn infants with ambient air or pure oxygen: a metaanalysis. Biol Neonate 2005; 87: 27–34.
54. Saugstad OD. Optimal oxygenation at birth and in the neonatal period. Neonatology 2007; 91(4): 319–322.
55. Saugstad OD, Ramji S, Vento M. Oxygen for newborn resuscitation: how much is enough? Pediatrics 2006; 118: 789–792.
56. Sola A, Deulofeut R. Oxygen and oxygenation in the delivery room. J Pediatr 2006; 148: 564–565.
57. Rabi Y, Rabi DR, Yee W. Room air resuscitation of the depressed newborn: A systematic review and meta-analysis. Resuscitation 2007; 72: 353–363.
58. Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo V, Vina J. Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term infants. Pediatrics 2001; 107: 642–647.
59. Cheung PY, Stevens JP, Haase E, Stang L, Bigam DL, Etches W et al. Platelet dysfunction in asphyxiated newborn piglets resuscitated with 21% and 100% oxygen. Pediatr Res 2006; 59: 540–636.
60. Markus T, Hansson S, Amer-Wa¨hlin I, Hellstro¨m-Westas L, Saugstad OD, Ley D. Cerebral inflammatory response after fetal asphyxia and hyperoxic resuscitation in newborn sheep. Pediatr Res 2007; 62(1): 71–77.
61. Andressen JH, Solberg R, Loberg EM, Munkeby BH, Stray-Pedersen B, Saugstad OD. Resuscitation with 21 or 100% oxygen in hypoxic nicotine-pretreated newborn piglets: possible neuroprotective effects of nicotine. Neonatology 2007; 93: 36–44.
62. Lakshminrusimha S, Russell JA, Steinhorn RH, Ryan RM, Gugino SF, Morin III FC et al. Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res 2006; 59: 137–141.
63. Saugstad OD. Take a breathFbut do not add oxygen (if not needed). Acta Paediatr 2007; 96: 789–800.
64. Naumburg E, Bellocco R, Cnattingius S, Johnson A, Ekbom A. Supplementary oxygen and risks of childhood lymphatic leukaemia. Acta Pediatr 2002; 91: 1233–1328.
65. Spector LG, Klebanoff MA, Feussner JH, Georgieff MK, Ross JA. Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005; 147: 27–31.
66. Paneth N. The evidence mounts against use of pure oxygen in newborn resuscitation. J Pediatr 2005; 147: 4–6.